Investigator #107 — Torrance, California

Investigator #107 is a clinical research site located in Torrance, California, United States 90505.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator #107 has participated in 1 clinical trials.

Therapeutic areas: Kerato Conjunctivitis Sicca.

Sponsors: Kala Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Torrance

Browse all research sites in California · View every site in Torrance

• Little Company of Mary Hospital
• Harbor University of California Los Angeles Center CRS
• University of California at Los Angeles
• University of California
• Del Amo Hospital
• Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
• 603, Harbor University of California Los Angeles Center CRS
• Harbor Hospital / UCLA
• University of California, Los Angeles-Harbor
• Harbor-University of California Los Angeles Medical Center
• Good Samaritan Hospital
• Torrance Memorial Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator #107?

Investigator #107 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator #107 conducted?

Investigator #107 has 1 clinical trials on record. Their work covers Kerato Conjunctivitis Sicca.

Is Investigator #107 accredited by Crixeo Clinical Trials?

Investigator #107 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator #107?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.